Viewing nowGlibeta Tablets 2 mg (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
A pharmaceutical Co., Ltd.

MFDS item code 200401108 · Notified 2004.09.30 · Insurance code 650200090
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with dietary management and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can also be administered alone, but in cases where oral hypoglycemic agents do not adequately control blood sugar, it can be used in combination with insulin. Additionally, when blood sugar control is insufficient with monotherapy using sulfonylureas or metformin, it is administered together with metformin to enhance blood sugar management. This medication is used to improve patients' blood sugar levels and aid in diabetes management.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional effect with doses above 4 mg, although some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider concomitant use with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the instructions given under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the efficacy and duration of action of the previously administered medicine. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediately taking sugar. Hypoglycemia may recur after initial successful management during treatment with sulfonylureas. Therefore, monitor patients carefully. Severe hypoglycemia requires immediate treatment and follow-up by a physician and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) is over 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately once a week according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Adjust the insulin dose periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes or who experience diabetic ketoacidosis or coma. Also, individuals with allergies to this drug or its components should not take it. There is no experience using this medication in patients with severe liver or kidney dysfunction, so switching to insulin therapy is recommended. Women who are pregnant or may become pregnant and breastfeeding women should not take this medication. In patients with severe infections, before and after surgery, or those with severe injuries, insulin therapy is needed instead of this medication. If gastrointestinal disturbances such as diarrhea or vomiting occur, absorption of food may be impaired, increasing the risk of hypoglycemia. Additionally, this medication contains lactose; patients with lactose intolerance or certain genetic disorders should not take it. During the initial week of dosing, the risk of hypoglycemia is high, so blood sugar levels should be closely monitored. Caution is particularly needed for the elderly, those with poor nutritional status or irregular eating habits, and frequent alcohol consumers. Patients with unbalanced exercise and food intake, or those with weak kidney and liver functions may also be more sensitive to hypoglycemia. The risk of hypoglycemia can increase in patients with other endocrine disorders or those who overdose on medications. Interactions with other medications taken alongside this medication can also affect blood sugar control, so it is important to inform your doctor or pharmacist. The most common side effect of this medication is hypoglycemia, which may manifest as headache, severe hunger, nausea, fatigue, confusion, drowsiness, or loss of consciousness. If symptoms of hypoglycemia appear, sugar-rich food should be consumed immediately, and in severe cases, emergency treatment may be necessary. Temporary blurred vision, gastrointestinal symptoms, or liver function abnormalities may occur during initial dosing or during significant blood sugar changes. Rarely, severe side effects such as blood abnormalities, allergic reactions, or hepatitis may occur, and if any unusual symptoms arise, immediate consultation with a physician is required. This medication should be taken regularly and must be combined with dietary management and exercise therapy for optimal blood sugar control. To reduce the risk of hypoglycemia, always have sugar available, and discuss hypoglycemic symptoms and treatment options with family members. In stressful situations or when blood sugar control is difficult due to surgery or infection, switching to insulin therapy may be necessary. Regular monitoring of blood sugar and urine sugar tests should be conducted during treatment, and if symptoms change, consult your doctor immediately. This medication should not be used during pregnancy or breastfeeding, as it may harm the fetus or newborn. Its safety and efficacy have not been established in children under 18 years of age, so its use is not recommended. Caution should be exercised in the elderly, as decreased renal function may lead to a delayed drug elimination, necessitating dosage adjustments. In the event of an overdose, severe hypoglycemia may occur, requiring immediate emergency measures such as inducing vomiting, gastric lavage, or intravenous glucose administration. Keep this medication out of the reach of children and store it in its original container to maintain quality.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggressiveness, decreased concentration, reduced agility or drive, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, transient mental confusion, convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitive reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Maintaining a storage temperature between 1 degree and 30 degrees Celsius is recommended. Proper storage helps to keep the medication's efficacy and safety for a longer period.
Green oblong tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
A pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.